Doctors explain how effective the first GLP-1 weight loss pill is, as well as its side effects, where to get it, and how much ...
Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg ...
The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a ...
Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...
GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...
There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to ...
Vietnam Investment Review on MSN
Ascletis gets FDA clearance for oral GLP 1 diabetes study
ASC30 was discovered and developed in-house at Ascletis as a first and only investigational small molecule GLP-1R fully ...
Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH ...
Everyday Health on MSN
The surprising potential of Ozempic and other GLP-1 drugs for type 1 diabetes
GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...
US FDA clears Ascletis’ IND application for 13-week phase II study of oral small molecule GLP-1, ASC30, in participants with diabetes: Hong Kong Wednesday, January 7, 2026, 18:0 ...
Novo Nordisk has finally introduced the first-ever GLP-1 pill for weight loss, Wegovy, across the US, marking a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback